A public offering of around 6.54 million shares of common stock has brought in $36 million for Apollo Endosurgery. Proceeds from the offering, which included the exercise of an overallotment option for underwriters to purchase an additional 853,363 shares, will be used for the adoption of the company's endo-bariatric products, as well as to expand into new markets and develop new product lines.
Offering pulls in $36M for Apollo Endosurgery
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.